HBIO

NASDAQStock

Harvard Bioscience, Inc.

$0.46-0.03 (-6.31%)

52-Week Range

$0.28

$0.79

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.45

Volume

289.5K

Avg Volume

399.4K

Performance

-11.79%

-29.75%

+12.40%

YTD

-24.22%

-23.75%

-81.29%

-92.62%

Price Chart

ETF Exposure

HBIO is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PQSV	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF	0.13%	2,384	$15K	$11.9M	—
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	60	$41	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,168	$1K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	10	$7	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,234,707	$618K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	6,494	$4K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	559	$379	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	398,432	$200K	$84.10B	0.05%

About HBIO ETF Exposure

Harvard Bioscience, Inc. (HBIO) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $0.46. Investors can gain exposure to HBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold HBIO, sorted by portfolio weight.